Skip to main content
Log in

Intraocular penetration of rifampin after oral administration

  • Laboratory Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Rifampin, the most potent anti-staphylococcal drug known, was examined for its penetration into the aqueous and vitreous of rabbits after a single oral dose of 150 mg, 300 mg, or 600 mg. Maximum levels after the 150 mg dose were achieved at 4 h and were 4.2 µg/ml in the aqueous and 2.2 µg/ml in the vitreous. After the 300 mg dose, maximum levels were also achieved at 4 h, and were 5.0 µg/ml in the aqueous and 2.6 µg/ml in the vitreous. The 600 mg dose produced maximum levels at 6 h after administration, with 20.0 µg/ml in the aqueous and 15.2 µg/ml in the vitreous. These levels exceed the mimimum inhibitory concentration for many microorganisms and suggest additional investigation into possible applications of systemic rifampin in the prophylaxis and treatment of bacterial endophthalmitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Archer G, Tenenbaum MJ, Haywood HB (1978) Rifampin therapy ofS. epidermidis: use in infections from indwelling artificial devices. JAMA 240:751–753

    Article  PubMed  CAS  Google Scholar 

  2. Cayley FE, Majumdar SK (1976) Ocular toxicity due to rifampicin. Br Med J 60:199–200

    Google Scholar 

  3. Council on Drugs, American Medical Association (1972) Evaluation of a new antituberculous agent. JAMA 220:414–415

    Article  Google Scholar 

  4. Farr B, Mandell GL (1982) Rifampin. Med Clin North Am 66:157–168

    PubMed  CAS  Google Scholar 

  5. Feldman MF, Moses RA (1977) Corneal penetration of rifampin. Am J Ophthalmol 83:862–865

    PubMed  CAS  Google Scholar 

  6. Furesz S (1970) Chemical and biological properties of rifampicin. Antibiot Chemother 16:316–351

    PubMed  CAS  Google Scholar 

  7. Girling DJ (1976) Ocular toxicity due to rifampicin. Br Med J 60:585

    Google Scholar 

  8. Girling DJ (1977) Adverse reaction to rifampicin in antituberculosis regimens. J Antimicrob Chemother 3:115–132

    Article  PubMed  CAS  Google Scholar 

  9. Grosset J, Leventis SA (1983) Adverse effects of rifampin. Rev Infect Dis [Suppl 3] 5:440–446

    Google Scholar 

  10. Lou P, Kazdan J, Bannatyne RM, Cheung R (1977) Successful treatment ofCandida endophthalmitis with a synergistic combination of Amphotericin B and rifampin. Am J Ophthalmol 83:12–15

    PubMed  CAS  Google Scholar 

  11. Lyons RW (1979) Orange contact lenses from rifampin. N Engl J Med 300:372–373

    PubMed  CAS  Google Scholar 

  12. Mandell GL (1973) Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest 52:1673–1679

    PubMed  CAS  Google Scholar 

  13. Mandell GL, Sande MA (1985) Drugs used in the chemotherapy of tuberculosis and leprosy. In: Goodman A, Gilman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. Macmillan, New York, pp 1202–1205

    Google Scholar 

  14. McCracken GH, Ginsburg CM, Zwieghaft TC, Clahsen J (1980) Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis againstHaemophilus influenzae type B disease. Pediatrics 66:17–21

    PubMed  Google Scholar 

  15. Mikuni M, Ohishi M, Suda S, Imai M, Takahashi T (1970) Rifampicin in ophthalmology. Acta Medica et Biologica 18:201–210

    PubMed  CAS  Google Scholar 

  16. Musini A, Cattani F, Bonora F (1970) Emploi de la rifampicine en ophtalmologie. Arch Ophtalmol (Paris) 30:809–816

    CAS  Google Scholar 

  17. Naveh Y, Friedman A (1973) Rifampicin therapy in Gramnegative bacteremia in infancy. Arch Dis Child 48:967–969

    Article  PubMed  CAS  Google Scholar 

  18. Norden CW (1975) Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin. J Infect Dis 132:493–499

    PubMed  CAS  Google Scholar 

  19. Pavan PR, Brinser JH (1987) Exogenous bacterial endophthalmitis treated without systemic antibiotics. Am J Ophthalmol 104:121–126

    PubMed  CAS  Google Scholar 

  20. Sabath LD, Garner C, Wilcox C (1976) Susceptibility ofStaph. aureus andStaph. epidermidis to 65 antibiotics. Antimicrob Agents Chemother 9:962–969

    PubMed  CAS  Google Scholar 

  21. Sande MA, Scheld WM (1980) Combination antibiotic therapy of bacterial endocarditis. Ann Int Med 92:390–395

    PubMed  CAS  Google Scholar 

  22. Scheld WM, Fletcher DD, Fink FN, Sande MA (1979) Response to therapy in an experimental rabbit model of meningitis due toListeria monocytogenes. J Infect Dis 140:287–294

    PubMed  CAS  Google Scholar 

  23. Smolin G, Okumoto M (1972) Effect of rifampicin onProteus keratitis. Am J Ophthalmol 73:40–45

    PubMed  CAS  Google Scholar 

  24. Stern GA, Okumoto M, Smolin G (1979) Combined Amphotericin B and rifampin treatment of experimentalCandida albicans keratitis. Arch Ophthalmol 97:721–722

    PubMed  CAS  Google Scholar 

  25. Thornsberry C, Baker CN, Kirven LA (1978) In vitro activity of antimicrobial agents on Legionnaire’s disease bacterium. Antimicrob Agents Chemother 13:78–80

    PubMed  CAS  Google Scholar 

  26. Wilkie J, Smolin G, Okumoto M (1972) The effect of rifampicin onPseudomonas keratitis. Can J Ophthalmol 7:309–313

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by NEI grant EY04474 (Dr. D’Amico)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, K.W., D’Amico, D.J., Oum, B.S. et al. Intraocular penetration of rifampin after oral administration. Graefe’s Arch Clin Exp Ophthalmol 228, 40–43 (1990). https://doi.org/10.1007/BF02764289

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02764289

Keywords

Navigation